This is our users words about us and our software products.
I have been a Medviso user for almost 15 years. This software is very flexible and the technical support superb! I can recommend it for anyone interested in quantification
Jan Engvall, professor
Linkoping University Hospital
Medviso’s Segment provides an invaluable software platform for cardiac imaging analysis that both provides excellent tools, but also a powerful and flexible platform for developing implementing your own plug-ins for new tools. The staff at Medviso provide an exceptional speed of service, technical expertise, and enthusiasm for research that has been instrumental for the success of our clinical and translational research.
Martin Ugander, MD, PhD, Associate Professor
Karolinska Institutet, Stockholm, Sweden
We have been using Medviso products since 2011 (currently, it is Segment CMR with strain module). In the university hospital setting, with two scanners in the lab (1,5T and 3,0T, from two vendors), a multi-vendor external software was necessary for comparisons and verification. Having been already familiar with Segment as a free software package, we went for Segment commercial products. The price/benefit ratio seemed by far the most appealing. We have been offered timely onsite training and good working contact was maintained thereafter – with frequent PACS settings changes that were periodically implemented in our hospital, we needed assistance at times. Even when this required some exchange with third parties, solutions were in place fast, while we continued our usual routine. As end-users, we appreciate the fact that Segment CMR package is evolving. New features are being added and the UI is continuously optimized.
Last, but not least, using Medviso products resulted in additional research opportunities. Working with Medviso is an entirely positive experience.
Karolina Dorniak MD, PhD
Medical University of Gdansk.
Segment has been of great use to us in multiple drug discovery studies with cardiac endpoints. We especially appreciate Medviso’s willingness to adapt their analysis platform to customer input.
Chief Strategy Officer, Antaros Medical